Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta in critically ill patients: effects on renal function and transfusion requirements
2008-003733-24Phase 4Terminated
- Sponsor
- Swansea Bay University Health Board
- Start
- Oct 2008
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in sepsis, acute kidney failure (AKF) and multiple organ dysfunction syndrome (MODS) comparing Neo-recormon with Placebo (2 arms). Started Oct 2008; status: terminated.
02
Drugs
epoetin beta
03
Conditions
sepsisacute kidney failure (AKF)multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on 2008-003733-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003733-24.